FindTrial
Sign In

A study for long-term prognosis in hospitalized novel coronavirus pneumonia (COVID-19) patients

A study for long-term prognosis in hospitalized novel coronavirus pneumonia (COVID-19) patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033723
Enrollment
Unknown
Registered
2020-06-10
Start date
2020-06-09
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Nil

Sponsors

Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients hospitalized in Wuhan Jinyintan due to COVID-19

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
Follow-up questionnaire: included improved BMA dyspnea index, measurement of quality of life questionnaire, and cardiovascular and cerebrovascular system (cardiovascular and cerebrovascular events);Cooperate with test item: 6 minute walk test.;Laboratory tests: renal function (including at least creatinine) + random blood glucose test and hemoglobin a1c;The lopinavir/Ritonavir cohort was tested for neutralizing antibodies.;Special items: respiratory system (chest HRCT, lung function (30min)), abdomen (liver, gallbladder, spleen, pancreas, kidney and portal vein) and lower limb venous ultrasound (30min);—

Countries

China

Contacts

Public ContactZhang DY, Huang CL, Cao B

Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital)

1813886398@qq.com+86 13507117929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026